Xynomic Pharmaceuticals Holdings, Inc.

CIK 1697805 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xynomic Pharmaceuticals Holdings, Inc..

Recent SEC filings

FiledFormAccession number
Jul 6, 202015-15D0001213900-20-016709
Jul 6, 2020RW0001213900-20-016708
Jun 29, 2020NT 10-Q0001213900-20-016104
Jun 29, 20208-K0001213900-20-016106
Jun 1, 202010-K0001213900-20-013743
May 14, 20208-K0001213900-20-012237
May 14, 2020NT 10-K0001213900-20-012234
Mar 30, 20208-K0001213900-20-007859
Mar 27, 20208-K0001213900-20-007647
Feb 13, 2020SC 13G/A0001062993-20-000770
Feb 12, 2020SC 13G/A0001493152-20-002073
Nov 14, 201910-Q0001213900-19-023569
Sep 27, 20198-K0001213900-19-019187
Sep 23, 20198-K0001213900-19-018592
Sep 23, 201925-NSE0001354457-19-000467
Sep 20, 20198-K0001213900-19-018509
Sep 13, 20198-K0001213900-19-017965
Sep 6, 20198-K0001213900-19-017326
Aug 30, 20198-K0001213900-19-016975
Aug 27, 20198-K0001213900-19-016725
Aug 16, 20198-K0001213900-19-016190
Aug 15, 201910-Q0001213900-19-016052
Aug 15, 2019NT 10-Q0001213900-19-015904
Aug 7, 20198-K0001213900-19-014797
Aug 6, 2019DEF 14A0001213900-19-014641